Paper Details

  1. Home
  2. Paper Details

[Combination therapy of high dose doxifluridine (5'-DFUR)+mitomycin C (MMC) for advanced or recurrent colorectal cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs].

Author: FukudaI, IrieK, IwanagaT, KikkawaN, OkumuraS, SakaiK, ShimoyamaT, TaguchiT, TerasawaT, YasutakeK

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study found that high-dose 5'-DFUR+MMC chemotherapy was effective in treating advanced and recurrent colorectal cancers, especially those with pulmonary metastases. The most common side effects were gastrointestinal.
Paper Details　
Original Abstract of the Article :
A co-study was conducted on treatment with high dose 5'DFUR+MMC in order to determine its effectiveness as a systemic chemotherapy in patients with advanced and recurrent colorectal cancers. The treatment schedule included 5'-DFUR given orally at a dose of 1,600 mg/body/day for five consecutive days...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/8422175

データ提供：米国国立医学図書館（NLM）

Combination Therapy for Colorectal Cancer: A New Path Through the Desert of Treatment

Advanced or recurrent colorectal cancer is a challenging condition, often described as a vast and unforgiving desert. This study investigates the effectiveness of a combination therapy using high-dose doxifluridine (5'-DFUR) and mitomycin C (MMC) in treating patients with advanced or recurrent colorectal cancer. It's like finding a new caravan route through the desert, one that offers a more promising path towards recovery.

5'-DFUR and MMC: A Potent Combination

The study demonstrates the effectiveness of this combination therapy, achieving a significant response rate in patients with advanced or recurrent colorectal cancer. It's like finding a well-equipped caravan with experienced guides and powerful resources, increasing the chances of survival in the harsh desert environment. The study highlights the potential for this combination therapy to improve outcomes for patients with advanced colorectal cancer.

Colorectal Cancer Treatment: Finding New Oases

This study provides hope for patients battling advanced or recurrent colorectal cancer, suggesting a new and effective treatment approach. It's like finding a new oasis in the desert, one that offers a chance for refreshment and rejuvenation. The study emphasizes the need for ongoing research to explore new treatment strategies and improve the lives of patients facing this challenging diagnosis.

Dr. Camel's Conclusion

The desert of colorectal cancer is a complex and challenging landscape. This study offers a glimmer of hope, showcasing a promising new treatment approach that could improve outcomes for patients. It's a reminder that even in the most difficult of circumstances, there is always potential for discovery and advancement. By embracing new treatment strategies and collaborating to find innovative solutions, we can make a difference in the lives of those battling this devastating disease.

Date :
  1. Date Completed 1993-02-12
  2. Date Revised 2015-11-23
Further Info :

Pubmed ID

8422175

DOI: Digital Object Identifier

8422175

Related Literature

Article Analysis
・Side Effects of floxuridine
SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.